<p>The Fifth Circuit Court issued a ruling that reinstates a requirement for patients to visit a health care provider in person to obtain mifepristone, a development described as upending abortion access in the United States.</p>
<p>The decision is currently under appeal, indicating that the legal dispute over how the medication can be accessed remains unresolved at this stage.</p>
<br><br><br><br>